Yuenong Jiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yuenong Jiao has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Jun Wu
Bioscience and Biomedical Engineering Thrust, The Hong Kong University of Science and Technology (Guangzhou), Nansha, Guangzhou 511400, China
3 shared publications Linlan Jiang
Department of Otorhinolaryngology Head and Neck Surgery, Guangzhou Twelfth People's Hospital (The Affiliated Twelfth People's Hospital of Guangzhou Medical University), Guangzhou Medical University, Guangzhou 510620, China; Institute of Otorhinolaryngology, Head and Neck Surgery, Guangzhou Medical University, Guangzhou 510620, China
3 shared publicationsShuyi Gao
Department of Otorhinolaryngology Head and Neck Surgery, Guangzhou Twelfth People's Hospital (The Affiliated Twelfth People's Hospital of Guangzhou Medical University), Guangzhou Medical University, Guangzhou 510620, China; Institute of Otorhinolaryngology, Head and Neck Surgery, Guangzhou Medical University, Guangzhou 510620, China
3 shared publicationsLiwen Wang
Department of Otorhinolaryngology Head and Neck Surgery, Guangzhou Twelfth People's Hospital (The Affiliated Twelfth People's Hospital of Guangzhou Medical University), Guangzhou Medical University, Guangzhou 510620, China; Institute of Otorhinolaryngology, Head and Neck Surgery, Guangzhou Medical University, Guangzhou 510620, China
2 shared publications- Tianqi Nie
Department of Otorhinolaryngology Head and Neck Surgery, Guangzhou Twelfth People's Hospital (The Affiliated Twelfth People's Hospital of Guangzhou Medical University), Guangzhou Medical University, Guangzhou 510620, China
2 shared publications - Huicheng Gong
Affiliated Guangzhou Twelfth People s Hospital of Guangzhou Medical University, Otorhinolaryngology, Guangzhou, 510000, China
1 shared publication
Latest Publications
- 18 June 2025
- Published by Elsevier in Trends in Biotechnology
- Vol. 44 (1) , 53-64
Auricular repair: symphony between scaffolds and stem cells
- 18 June 2025
- Published by Elsevier in Trends in Biotechnology
- Vol. 44 (1) , 53-64
Auricular repair: symphony between scaffolds and stem cells
- Open Access
- 1 May 2025
- Published by KEAI Publishing in Bioactive Materials
- Vol. 47, 51-63
Self-healable and pH-responsive spermidine/ferrous ion complexed hydrogel Co-loaded with CA inhibitor and glucose oxidase for combined cancer immunotherapy through triple ferroptosis mechanism
Tumor microenvironment governs various therapeutic tolerability of cancer such as ferroptosis and immunotherapy through rewiring tumor metabolic reprogramming like Warburg metabolism. Highly expressed carbonic anhydrases (CA) in tumor that maintaining the delicate metabolic homeostasis is thus the most potential target to be modulated to resolve the therapeutic tolerability. Hence, in this article, a self-healable and pH-responsive spermidine/ferrous ion hydrogel loaded with CA inhibitor (acetazolamide, ACZ) and glucose oxidase (ACZ/GOx@SPM-HA Gel) was fabricated through the Schiff-base reaction between spermidine-dextran and oxidized hyaluronic acid, along with ferrous coordination. Investigation on cancer cell lines (MOC-1) demonstrated ACZ/GOx@SPM-HA Gel may induce cellular oxidative stress and mitochondrial dysfunction through disrupting the cellular homeostasis. Moreover, with the facilitation of autophagy induced by spermidine, ACZ/GOx@SPM-HA Gel may trigger a positive feedback loop to maximally amplify cellular ferroptosis and promote DAMPs release. The anti-tumor evaluation on xenograft mice models furtherly proved the local injection of such hydrogel formulation could efficiently inhibit the tumor growth and distinctively promote the immunogenicity of tumor bed to provide a more favorable environment for immunotherapy. Overall, ACZ/GOx@SPM-HA Gel, with such feasible physiochemical properties and great biocompatibility, holds great potential in treating solid tumors with acidosis-mediated immunotherapy tolerance.
- 1 May 2025
- Published by KEAI Publishing in Bioactive Materials
- Vol. 47, 51-63
Open AccessSelf-healable and pH-responsive spermidine/ferrous ion complexed hydrogel Co-loaded with CA inhibitor and glucose oxidase for combined cancer immunotherapy through triple ferroptosis mechanism
Tumor microenvironment governs various therapeutic tolerability of cancer such as ferroptosis and immunotherapy through rewiring tumor metabolic reprogramming like Warburg metabolism. Highly expressed carbonic anhydrases (CA) in tumor that maintaining the delicate metabolic homeostasis is thus the most potential target to be modulated to resolve the therapeutic tolerability. Hence, in this article, a self-healable and pH-responsive spermidine/ferrous ion hydrogel loaded with CA inhibitor (acetazolamide, ACZ) and glucose oxidase (ACZ/GOx@SPM-HA Gel) was fabricated through the Schiff-base reaction between spermidine-dextran and oxidized hyaluronic acid, along with ferrous coordination. Investigation on cancer cell lines (MOC-1) demonstrated ACZ/GOx@SPM-HA Gel may induce cellular oxidative stress and mitochondrial dysfunction through disrupting the cellular homeostasis. Moreover, with the facilitation of autophagy induced by spermidine, ACZ/GOx@SPM-HA Gel may trigger a positive feedback loop to maximally amplify cellular ferroptosis and promote DAMPs release. The anti-tumor evaluation on xenograft mice models furtherly proved the local injection of such hydrogel formulation could efficiently inhibit the tumor growth and distinctively promote the immunogenicity of tumor bed to provide a more favorable environment for immunotherapy. Overall, ACZ/GOx@SPM-HA Gel, with such feasible physiochemical properties and great biocompatibility, holds great potential in treating solid tumors with acidosis-mediated immunotherapy tolerance.
- Open Access
- 19 November 2024
- Published by MDPI AG in Preprints.org
Sestrin2 Enhances Mitochondrial Function to Alleviate Age-Related Hearing Loss
Mitochondrial dysfunction and oxidative stress are key contributors to age-related hearing loss (ARHL). Sestrin2, a stress-inducible antioxidant protein, decreases with age, impacting various age-related diseases; however, its role in ARHL remains unclear. In this study, we initially assessed hearing in 8-week-old mice, followed by adeno-associated virus-mediated transfection of Sestrin2 into the posterior semicircular canal. At 26 weeks, hearing was reassessed, and cochlear samples were analysed. Immunofluorescence staining revealed Sestrin2 localization and mitophagy marker PINK1 expression, and TUNEL staining was used to assess hair cell apoptosis rate. We also measured mitochondrial membrane potential and examined AMPKα, mTOR, PINK1, Parkin, and Sestrin2 protein levels. Results showed reduced Sestrin2 in ARHL-affected hair cells, leading to mitochondrial dysfunction and increased apoptosis. Sestrin2 overexpression enhanced mitochondrial membrane potential, ATP levels, and mitochondrial function, delaying hair cell ageing and apoptosis and improving hearing. Furthermore, AMPK activation inhibited mTOR to promote mitophagy as the cells aged, whereas Sestrin2 overexpression inhibited this pathway, directly protecting hair cells. These findings highlight Sestrin2’s critical role in auditory health and its potential as a therapeutic target for delaying ARHL.
- 19 November 2024
- Published by MDPI AG in Preprints.org
Open AccessSestrin2 Enhances Mitochondrial Function to Alleviate Age-Related Hearing Loss
Mitochondrial dysfunction and oxidative stress are key contributors to age-related hearing loss (ARHL). Sestrin2, a stress-inducible antioxidant protein, decreases with age, impacting various age-related diseases; however, its role in ARHL remains unclear. In this study, we initially assessed hearing in 8-week-old mice, followed by adeno-associated virus-mediated transfection of Sestrin2 into the posterior semicircular canal. At 26 weeks, hearing was reassessed, and cochlear samples were analysed. Immunofluorescence staining revealed Sestrin2 localization and mitophagy marker PINK1 expression, and TUNEL staining was used to assess hair cell apoptosis rate. We also measured mitochondrial membrane potential and examined AMPKα, mTOR, PINK1, Parkin, and Sestrin2 protein levels. Results showed reduced Sestrin2 in ARHL-affected hair cells, leading to mitochondrial dysfunction and increased apoptosis. Sestrin2 overexpression enhanced mitochondrial membrane potential, ATP levels, and mitochondrial function, delaying hair cell ageing and apoptosis and improving hearing. Furthermore, AMPK activation inhibited mTOR to promote mitophagy as the cells aged, whereas Sestrin2 overexpression inhibited this pathway, directly protecting hair cells. These findings highlight Sestrin2’s critical role in auditory health and its potential as a therapeutic target for delaying ARHL.
- Open Access
- 1 October 2024
- Published by SAGE Publications in Science Progress
- Vol. 107 (4)
Treatments in sinonasal inverted papilloma malignancy invading the pterygopalatine fossa: A case report
Sinonasal inverted papilloma (SNIP) is less malignant and usually occur in the maxillary sinus. However, cases invading the pterygopalatine fossa are extremely rare. In this article, we describe a rare case of a man in his early 60s who presented with left nasal congestion, headache, epistaxis, and facial numbness. The patient underwent a comprehensive treatment primarily based on surgery. Nasal endoscopy showed that the mass had invaded the left infratemporal fossa laterally and was poorly separated from the internal maxillary artery, which increased the complexity and difficulty of the surgery. In addition, the patient had previously undergone nasal cavity surgery, which made the surgery more challenging. In order to reduce the risk of recurrence, we exposed the infratemporal fossa region under nasal endoscopic guidance with a combined labial and gingival incision, and completely removed the tumor base and tumor margins. There were no postoperative complications and no recurrence was observed during the 2-year follow-up period.
- 1 October 2024
- Published by SAGE Publications in Science Progress
- Vol. 107 (4)
Open AccessTreatments in sinonasal inverted papilloma malignancy invading the pterygopalatine fossa: A case report
Sinonasal inverted papilloma (SNIP) is less malignant and usually occur in the maxillary sinus. However, cases invading the pterygopalatine fossa are extremely rare. In this article, we describe a rare case of a man in his early 60s who presented with left nasal congestion, headache, epistaxis, and facial numbness. The patient underwent a comprehensive treatment primarily based on surgery. Nasal endoscopy showed that the mass had invaded the left infratemporal fossa laterally and was poorly separated from the internal maxillary artery, which increased the complexity and difficulty of the surgery. In addition, the patient had previously undergone nasal cavity surgery, which made the surgery more challenging. In order to reduce the risk of recurrence, we exposed the infratemporal fossa region under nasal endoscopic guidance with a combined labial and gingival incision, and completely removed the tumor base and tumor margins. There were no postoperative complications and no recurrence was observed during the 2-year follow-up period.
- 5 July 2024
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 12 (16) , 4006-4023
Biomaterials as a new option for treating sensorineural hearing loss
Biomaterials as a new option has revolutionized the treatment of sensorineural hearing loss.
- 5 July 2024
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 12 (16) , 4006-4023
Biomaterials as a new option for treating sensorineural hearing loss
Biomaterials as a new option has revolutionized the treatment of sensorineural hearing loss.
- 1 May 2020
- Vol. 34 (5) , 447-451
沉浸式虚拟现实系统辅助前庭功能康复的应用
探讨虚拟现实(VR)技术辅助前庭康复训练(VRT)治疗慢性前庭功能低下的作用和价值。 按机械抽样方法将98例慢性前庭功能低下患者分为实验组(VR组)73例和控制组25例,VR组采取沉浸式VR辅助VRT方法治疗,控制组采取常规VRT治疗。治疗前和治疗后第12周,采用汉化眩晕症状量表(VSS-C)进行评分,评估患者治疗前后眩晕症状变化。平衡功能评估采用平衡仪测定人体中心压力(COP)、最大摆动长度(MOL)及COP摆动包络面积(EA)数据,数字越小表示平衡能力越好。采用SPSS 20.0统计软件进行数据分析。 ① VR组治疗后12周较治疗前VSS-C量表总分、平衡相关得分差异有统计学意义(P < 0.01)。治疗后2组VSS-C量表总分(P < 0.01)、平衡相关得分(P < 0.05)差异有统计学意义。②平衡仪COP测定,2种训练方法治疗12周前后,MOL、EA睁眼状态下差异均有统计学意义(P < 0.01)。 VRT引入VR技术能够在训练中为患者提供有趣的互动,鼓励患者更积极主动地参与康复锻炼,达到良好效果。VR技术在患者无视力障碍的前提下对主观平衡康复的疗效优于常规VRT训练方法。
- 1 May 2020
- Vol. 34 (5) , 447-451
沉浸式虚拟现实系统辅助前庭功能康复的应用
探讨虚拟现实(VR)技术辅助前庭康复训练(VRT)治疗慢性前庭功能低下的作用和价值。 按机械抽样方法将98例慢性前庭功能低下患者分为实验组(VR组)73例和控制组25例,VR组采取沉浸式VR辅助VRT方法治疗,控制组采取常规VRT治疗。治疗前和治疗后第12周,采用汉化眩晕症状量表(VSS-C)进行评分,评估患者治疗前后眩晕症状变化。平衡功能评估采用平衡仪测定人体中心压力(COP)、最大摆动长度(MOL)及COP摆动包络面积(EA)数据,数字越小表示平衡能力越好。采用SPSS 20.0统计软件进行数据分析。 ① VR组治疗后12周较治疗前VSS-C量表总分、平衡相关得分差异有统计学意义(P < 0.01)。治疗后2组VSS-C量表总分(P < 0.01)、平衡相关得分(P < 0.05)差异有统计学意义。②平衡仪COP测定,2种训练方法治疗12周前后,MOL、EA睁眼状态下差异均有统计学意义(P < 0.01)。 VRT引入VR技术能够在训练中为患者提供有趣的互动,鼓励患者更积极主动地参与康复锻炼,达到良好效果。VR技术在患者无视力障碍的前提下对主观平衡康复的疗效优于常规VRT训练方法。